Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Recommendation of “Hold” by Analysts
Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) has received an average rating of “Hold” from the twelve ratings firms that are covering the company, MarketBeat.com reports. Twelve research analysts have rated the stock with a hold rating. The average twelve-month target price among brokers that have issued ratings on the stock in the last […]
Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) has received an average rating of “Hold” from the twelve ratings firms that are covering the company, MarketBeat.com reports. Twelve research analysts have rated the stock with a hold rating. The average twelve-month target price among brokers that have issued ratings on the stock in the last […]
